U.S. Pharmacy Market Size, Share & Trends Analysis Report By Product (Prescription, OTC), By Type (Hospital Pharmacy, Retail Pharmacy, ePharmacy), By Ownership, By Country, And Segment Forecasts, 2026 - 2033

Table of Contents

Chapter 1. Report Scope & Research Methodology

• 1.1 Market Segmentation
  • 1.1.1 Segment Definition
    • 1.1.1.1 Product
    • 1.1.1.2 Type
    • 1.1.1.3 Ownership
• 1.2 Estimates and Forecast Timeline
• 1.3 Research Methodology
  • 1.3.1 Information Procurement
  • 1.3.2 Purchased Database
  • 1.3.3 GVR's Internal Database
  • 1.3.4 Secondary Sources
  • 1.3.5 Primary Research
  • 1.3.6 Details Of Primary Research
• 1.4 Information or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Three Pillars of Market Estimation
    • 1.6.1.1 Secondary Market Research
    • 1.6.1.2 Primary Market Intelligence
      • 1.6.1.2.1 In-Depth Interviews (IDIs)
      • 1.6.1.2.2 Online Survey Program
  • 1.6.2 Market Modeling & Forecasting
    • 1.6.2.1 Model 1: Volume-Price Analysis
      • 1.6.2.1.1 Step 1: Prescription volume estimation
      • 1.6.2.1.2 Channel-Wise Methodology
        • 1.6.2.1.2.1 Retail Chains (CVS, Walgreens, etc.)
        • 1.6.2.1.2.2 Supermarket Pharmacies (Kroger, Albertsons, Publix)
        • 1.6.2.1.2.3 Health System / Hospital Outpatient Pharmacies
        • 1.6.2.1.2.4 Independent Pharmacies
        • 1.6.2.1.2.5 Mail-Order Pharmacies
        • 1.6.2.1.2.6 Specialty / Central Fill Pharmacies
        • 1.6.2.1.2.7 Long-Term Care (LTC) and Defense-Related Pharmacies
        • 1.6.2.1.2.8 ePharmacies (Amazon, Capsule, Hims & Hers, etc.)
        • 1.6.2.1.2.9 Other Channels
        • 1.6.2.1.2.10 Aggregation & Triangulation
      • 1.6.2.1.3 Step 2: Determining Average Realized Price (ARP)
      • 1.6.2.1.4 Step 2: OTC Revenue
    • 1.6.2.2 Model 2: Company Market Share Analysis
      • 1.6.2.2.1 Step 1: Public Filings
      • 1.6.2.2.2 Step 2: Private & Independent Estimates
      • 1.6.2.2.3 Step 3: Market Share Allocation
    • 1.6.2.3 CAGR/Forecasting Calculations & Assumptions
      • 1.6.2.3.1 Key Forecasting Drivers and Weights
      • 1.6.2.3.2 Scenario Framework (2026 - 2033)
      • 1.6.2.3.3 Factor-Based Impact Assessment
  • 1.6.3 Estimation Process: Pharmacy Split By Catchment Area
    • 1.6.3.1 Data Sources
    • 1.6.3.2 Estimation Process
  • 1.6.4 Estimation Process: Pharmacy Split By Product Form
  • 1.6.5 Company-Level Metric's Estimation
    • 1.6.5.1 Financial Performance
      • 1.6.5.1.1 2025 Revenue & EBITDA (Pharmacy-Only)
      • 1.6.5.1.2 5-Year Forecast of Revenue & EBITDA
      • 1.6.5.1.3 Balance Sheet Health Indicators
    • 1.6.5.2 Volumes & Operations
      • 1.6.5.2.1 2025 Total Prescriptions; 5-Year Rx Forecast
      • 1.6.5.2.2 % Fulfilled via Central Fill; Volumes Split by Catchment Area
• 1.7 List of Secondary Sources
• 1.8 List of Abbreviations
• 1.9 Research Objectives
  • 1.9.1 Objective - 1
  • 1.9.2 Objective - 2
  • 1.9.3 Objective - 3

Chapter 2. Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Outlook - I
• 2.3 Segment Outlook- II
• 2.4 Competitive Scenario

Chapter 3. U.S. Pharmacy Market - Industry Outlook

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Related Market Outlook
    • 3.1.2.1 U.S. pharmacy benefit management market
• 3.2 Market Dynamics
  • 3.2.1 Market Driver Analysis
    • 3.2.1.1 Increasing prevalence of chronic diseases
    • 3.2.1.2 Technological advancements
    • 3.2.1.3 Expanding health insurance coverage
    • 3.2.1.4 Increasing demand for specialty drugs
  • 3.2.2 Market Restraint Analysis
    • 3.2.2.1 Product recalls and lawsuits
    • 3.2.2.2 Lack of trained staff
  • 3.2.3 Market Opportunity Analysis
  • 3.2.4 Market Challange Analysis
• 3.3 Regulatory Scenario & Reimbursement Outlook
  • 3.3.1 Regulatory Scenario
  • 3.3.2 Reimbursement Scenario
• 3.4 Business Environment Analysis Tools
  • 3.4.1 Porter's Five Forces Analysis
  • 3.4.2 Pestle Analysis

Chapter 4. U.S. Pharmacy Market: Product Estimates & Trend Analysis

• 4.1 U.S. Pharmacy Market: Product Segment Dashboard
• 4.2 Product Movement & Market Share Analysis, 2025 & 2033
• 4.3 U.S. Pharmacy Market Size & Forecast and Forecasts, By Product (USD Billion)
  • 4.3.1 Prescription
    • 4.3.1.1 Prescription market, 2021 - 2033 (USD Billion)
  • 4.3.2 Over-the-Counter (OTC)
    • 4.3.2.1 OTC market, 2021 - 2033 (USD Billion)

Chapter 5. U.S. Pharmacy Market: Type Estimates & Trend Analysis

• 5.1 U.S. Pharmacy Market: Type Segment Dashboard
• 5.2 Type Movement & Market Share Analysis, 2025 & 2033
• 5.3 U.S. Pharmacy Market Size & Forecast and Forecasts, By Type, 2021 - 2033 (USD Billion)
• 5.4 U.S. Pharmacy Market: Estimated Number of Pharmacies, By Type, 2021 - 2033 (Unit)
• 5.5 U.S. Pharmacy Market: Estimated Prescription Volume, By Type, 2021 - 2033 (Million)
• 5.6 U.S. Pharmacy Market: Estimated Prescription Volume, By Catchment Area, 2025 (%)
• 5.7 U.S. Pharmacy Market: Estimated Prescription Volume, By Filled Prescriptions (TRx), 2025 (%)
  • 5.7.1 Retail Chains
    • 5.7.1.1 Retail chains market, 2021 - 2033 (USD Billion)
  • 5.7.2 Supermarket Pharmacies
    • 5.7.2.1 Supermarket pharmacies market, 2021 - 2033 (USD Billion)
  • 5.7.3 Health System / Hospital Pharmacy
    • 5.7.3.1 Health system / Hospital pharmacy market, 2021 - 2033 (USD Billion)
  • 5.7.4 Independent Pharmacies
    • 5.7.4.1 Independent pharmacies market, 2021 - 2033 (USD Billion)
  • 5.7.5 Mail-Order Pharmacies
    • 5.7.5.1 Mail-order pharmacy market, 2021 - 2033 (USD Billion)
  • 5.7.6 Specialty / Central Fill Pharmacies
    • 5.7.6.1 Specialty / central fill pharmacies market, 2021 - 2033 (USD Billion)
  • 5.7.7 Long-Term Care And Defense-Related Pharmacies
    • 5.7.7.1 Long-term care and defense-related pharmacies market, 2021 - 2033 (USD Billion)
  • 5.7.8 Epharmacy
    • 5.7.8.1 ePharmacy market, 2021 - 2033 (USD Billion)
  • 5.7.9 Others
    • 5.7.9.1 Others market, 2021 - 2033 (USD Billion)

Chapter 6. U.S. Pharmacy Market: Ownership Estimates & Trend Analysis

• 6.1 U.S. Pharmacy Market: Ownership Segment Dashboard
• 6.2 Ownership Movement & Market Share Analysis, 2026 & 2033
• 6.3 U.S. Pharmacy Market Size & Forecast and Forecasts, By Ownership, 2021 - 2033 (USD Billion)
  • 6.3.1 Chains
    • 6.3.1.1 Chains market, 2021 - 2033 (USD Billion)
  • 6.3.2 Independent
    • 6.3.2.1 Independent market, 2021 - 2033 (USD Billion)

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Specialty drug expenditures
• Table 4 U.S. pharmacy market revenue estimates and forecast, by product, 2021 - 2033 (USD Billion)
• Table 5 U.S. pharmacy market revenue estimates and forecast, by type, 2021 - 2033 (USD Billion)
• Table 6 U.S. pharmacy market: Estimated number of pharmacies, by type, 2021 - 2033 (Unit)
• Table 7 U.S. pharmacy market: Estimated prescription volume, by type, 2021 - 2033 (Million)
• Table 8 U.S. pharmacy market revenue estimates and forecast, by ownership, 2021 - 2033 (USD Billion)
• Table 9 U.S. pharmacy market: Estimated prescription volume, by catchment area, 2025 (%)
• Table 10 U.S. pharmacy market: Estimated prescription volume, by filled prescriptions (TRx), 2025 (%)

List of Figures

• Fig.1 U.S. pharmacy market segmentation
• Fig.2 Market research process
• Fig.3 Information procurement
• Fig.4 Primary research pattern
• Fig.5 Market research approaches
• Fig.6 Value-chain-based sizing & forecasting
• Fig.7 Market formulation & validation
• Fig.8 Market snapshot
• Fig.9 Segment outlook-I
• Fig.10 Segment outlook-II
• Fig.11 Competitive scenario
• Fig.12 U.S. pharmacy market: Parent market outlook
• Fig.13 U.S. pharmacy market: Ancillary/related market outlook
• Fig.14 U.S. pharmacy market dynamics
• Fig.15 Market driver relevance analysis (Current & future impact)
• Fig.16 Estimated New Cancer Cases, 2025
• Fig.17 Estimated U.S. prevalence of stroke, 2021 - 2033
• Fig.18 Estimated U.S. prevalence of prostate cancer, 2021 - 2033
• Fig.19 Estimated U.S. prevalence of kidney cancer, 2021 - 2033
• Fig.20 Market restraint relevance analysis (Current & future impact)
• Fig.21 Number of pharmacy degrees conferred 2021 - 2024 by gender
• Fig.22 U.S. pharmacy market: Porter's five forces analysis
• Fig.23 U.S. pharmacy market: PESTLE analysis
• Fig.24 U.S. pharmacy market: Product segment dashboard
• Fig.25 U.S. pharmacy market: Product market share analysis, 2025 & 2033
• Fig.26 Prescription market, 2021 - 2033 (USD Billion)
• Fig.27 OTC market, 2021 - 2033 (USD Billion)
• Fig.28 U.S. pharmacy market: Type segment dashboard
• Fig.29 U.S. pharmacy market: Type market share analysis, 2025 & 2033
• Fig.30 Retail pharmacy market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
• Fig.31 Supermarket pharmacies market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
• Fig.32 Health system / hospital pharmacy market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
• Fig.33 Independent pharmacies market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
• Fig.34 Mail-order pharmacy market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
• Fig.35 Specialty / central fill pharmacies market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
• Fig.36 Long-term care and defense-related pharmacies market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
• Fig.37 ePharmacy market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
• Fig.38 Others market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
• Fig.39 U.S. pharmacy market: Ownership segment dashboard
• Fig.40 U.S. pharmacy market: Ownership market share analysis, 2025 & 2033
• Fig.41 Chain pharmacy market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
• Fig.42 Independent pharmacy market, 2021 - 20332021 - 20332021 - 2033 (USD Billion)
• Fig.43 Key company categorization
• Fig.44 Estimated company market share analysis, 2025